A new biotech, Quarry Thera, secured $32 million in seed funding led by industry veterans Craig Crews and Mikael Dolsten, according to the company announcement. The round brings prominent scientific and executive experience to the startup’s launch and signals investor appetite for founder‑led ventures from established pharma leaders. The financing will support early research and candidate development as the company builds a preclinical pipeline.